INTERNATIONAL PATENT: SANEGENE BIO USA INC. FILES APPLICATION FOR "SMALL INTERFERING RNA TARGETING MYOSTATIN (MSTN) AND USES THEREOF"

GENEVA, March 4 -- SANEGENE BIO USA INC. (300 Tradecenter Dr, Suite 5500, Woburn, MA01801) filed a patent application (PCT/CN2025/115953) for "SMALL INTERFERING RNA TARGETING MYOSTATIN (MSTN) AND USES THEREOF" on Aug 20, 2025. With publication no. WO/2026/041067, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Peng (c/o Sanegene Bio USA Inc., 300 Tradecenter Dr, Suite 5500, Woburn, MA 01801), ZHOU, Chunxue (c/o Suzhou Sanegene Bio Inc., Room 301, Building B2, Phase III, BioBAY, 99 Jingu RdSuzhou, Jiangsu 215103), X...